Key facts
- This page summarizes Nicolas Barthelemy's Form 4 filing for Twist Bioscience Corp (TWST).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 Nov 2022, 15:16.
Nicolas Barthelemy - 21 Nov 2022 Form 4 Insider Report for Twist Bioscience Corp (TWST)
- Reporting relationship
- Director
- Issuer ticker
- TWST
- Reported as of
- 21 Nov 2022
- Net transaction value
- +$211,883
- SEC form
- 4
- Accepted by SEC
- 23 Nov 2022, 15:16:23 UTC
- Prior SEC filing
- 17 Jun 2022
- Next SEC filing
- 22 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alyssa Zhang, as Attorney-in-Fact for Nicolas Barthelemy
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Nicolas Barthelemy filed Form 4 for Twist Bioscience Corp (TWST) on 23 Nov 2022.
Change
- Previous filing in this sequence was filed on 17 Jun 2022.
- Current net transaction value: +$211,883.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TWST
transaction
Common Stock
Options Exercise
- Transaction value
- $211,883
- Shares
- +9,082
- Change %
- +65%
- Price
- $23.33
- Shares after
- 23,021
- Date
- 21 Nov 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TWST
transaction
Derivative
Director Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -9,082
- Change %
- -45%
- Price
- $0.000000
- Shares after
- 11,279
- Date
- 21 Nov 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,082
- Exercise price
- $23.33
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
1/3 of the shares subject to the option vest and become exercisable on the first anniversary of October 24, 2020, and 1/3rd of the shares subject to the option vest and become exercisable on each anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.